Janssen Defends Data Reanalysis in Risperdal Trial

Janssen Defends Data Reanalysis in Risperdal Trial
A Janssen Pharmaceuticals authorities and the statistician who just recently conducted a fiercely contested reanalysis of information supposedly linking Risperdal to …


Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *